EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE Alternext US: NBY, http://novabaypharma.com), a biopharmaceutical company developing products for the treatment or prevention of a wide range of bacterial and viral infections, will present at the 11th Annual BIO CEO & Investor Conference, the largest investor conference focused on publicly traded biotech companies. The event will be held at the Astor Room in the Waldorf-Astoria in New York City on Monday, February 9, 2009, at 10:30AM/EST.
